Antioxidant and antiinflammatory effect of Epilobium parviflorum Schreb.

B. T. Hevesi, P. J. Houghton, S. Habtemariam, A. Kéry

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Epilobium parviflorum Schreb. (Onagraceae) is used for the treatment of benign prostatic hyperplasia (BPH), but its biological action is not entirely identified. This paper aims to report data on E. parviflorum with respect to its antioxidant and antiinflammatory effects. The aqueous acetone extract of E. parviflorum showed higher antioxidant effect in the DPPH assay than well known antioxidants and inhibited the lipid peroxidation determined by the TBA assay (IC50 = 2.37 ± 0.12 mg/mL). In concentrations of 0.2-15.0 μg/mL the extract possessed a protective effect, comparable to catalase (250 IU/mL), against oxidative damage, generated in fibroblast cells. In the COX inhibition assay E. parviflorum decreased the PGE2 release, so showing inhibition of the COX-enzyme (IC50 = 1.4 ± 0.1 μg/mL).

Original languageEnglish
Pages (from-to)719-724
Number of pages6
JournalPhytotherapy Research
Volume23
Issue number5
DOIs
Publication statusPublished - May 2009

Fingerprint

Epilobium
Anti-Inflammatory Agents
Antioxidants
Inhibitory Concentration 50
Onagraceae
Prostatic Hyperplasia
Acetone
Dinoprostone
Catalase
Lipid Peroxidation
Fibroblasts
Enzymes

Keywords

  • BPH
  • COX-enzyme
  • DPPH
  • Epilobium parviflorum
  • Fibroblast
  • TBA

ASJC Scopus subject areas

  • Pharmacology
  • Medicine(all)

Cite this

Antioxidant and antiinflammatory effect of Epilobium parviflorum Schreb. / Hevesi, B. T.; Houghton, P. J.; Habtemariam, S.; Kéry, A.

In: Phytotherapy Research, Vol. 23, No. 5, 05.2009, p. 719-724.

Research output: Contribution to journalArticle

Hevesi, B. T. ; Houghton, P. J. ; Habtemariam, S. ; Kéry, A. / Antioxidant and antiinflammatory effect of Epilobium parviflorum Schreb. In: Phytotherapy Research. 2009 ; Vol. 23, No. 5. pp. 719-724.
@article{6d294ea706a24a47a8e1b429031d899c,
title = "Antioxidant and antiinflammatory effect of Epilobium parviflorum Schreb.",
abstract = "Epilobium parviflorum Schreb. (Onagraceae) is used for the treatment of benign prostatic hyperplasia (BPH), but its biological action is not entirely identified. This paper aims to report data on E. parviflorum with respect to its antioxidant and antiinflammatory effects. The aqueous acetone extract of E. parviflorum showed higher antioxidant effect in the DPPH assay than well known antioxidants and inhibited the lipid peroxidation determined by the TBA assay (IC50 = 2.37 ± 0.12 mg/mL). In concentrations of 0.2-15.0 μg/mL the extract possessed a protective effect, comparable to catalase (250 IU/mL), against oxidative damage, generated in fibroblast cells. In the COX inhibition assay E. parviflorum decreased the PGE2 release, so showing inhibition of the COX-enzyme (IC50 = 1.4 ± 0.1 μg/mL).",
keywords = "BPH, COX-enzyme, DPPH, Epilobium parviflorum, Fibroblast, TBA",
author = "Hevesi, {B. T.} and Houghton, {P. J.} and S. Habtemariam and A. K{\'e}ry",
year = "2009",
month = "5",
doi = "10.1002/ptr.2725",
language = "English",
volume = "23",
pages = "719--724",
journal = "Phytotherapy Research",
issn = "0951-418X",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Antioxidant and antiinflammatory effect of Epilobium parviflorum Schreb.

AU - Hevesi, B. T.

AU - Houghton, P. J.

AU - Habtemariam, S.

AU - Kéry, A.

PY - 2009/5

Y1 - 2009/5

N2 - Epilobium parviflorum Schreb. (Onagraceae) is used for the treatment of benign prostatic hyperplasia (BPH), but its biological action is not entirely identified. This paper aims to report data on E. parviflorum with respect to its antioxidant and antiinflammatory effects. The aqueous acetone extract of E. parviflorum showed higher antioxidant effect in the DPPH assay than well known antioxidants and inhibited the lipid peroxidation determined by the TBA assay (IC50 = 2.37 ± 0.12 mg/mL). In concentrations of 0.2-15.0 μg/mL the extract possessed a protective effect, comparable to catalase (250 IU/mL), against oxidative damage, generated in fibroblast cells. In the COX inhibition assay E. parviflorum decreased the PGE2 release, so showing inhibition of the COX-enzyme (IC50 = 1.4 ± 0.1 μg/mL).

AB - Epilobium parviflorum Schreb. (Onagraceae) is used for the treatment of benign prostatic hyperplasia (BPH), but its biological action is not entirely identified. This paper aims to report data on E. parviflorum with respect to its antioxidant and antiinflammatory effects. The aqueous acetone extract of E. parviflorum showed higher antioxidant effect in the DPPH assay than well known antioxidants and inhibited the lipid peroxidation determined by the TBA assay (IC50 = 2.37 ± 0.12 mg/mL). In concentrations of 0.2-15.0 μg/mL the extract possessed a protective effect, comparable to catalase (250 IU/mL), against oxidative damage, generated in fibroblast cells. In the COX inhibition assay E. parviflorum decreased the PGE2 release, so showing inhibition of the COX-enzyme (IC50 = 1.4 ± 0.1 μg/mL).

KW - BPH

KW - COX-enzyme

KW - DPPH

KW - Epilobium parviflorum

KW - Fibroblast

KW - TBA

UR - http://www.scopus.com/inward/record.url?scp=65649118111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65649118111&partnerID=8YFLogxK

U2 - 10.1002/ptr.2725

DO - 10.1002/ptr.2725

M3 - Article

C2 - 19107731

AN - SCOPUS:65649118111

VL - 23

SP - 719

EP - 724

JO - Phytotherapy Research

JF - Phytotherapy Research

SN - 0951-418X

IS - 5

ER -